Products for Research Use Only

Isoxepac-d6

CAT: 0804-HY-W050088SSize: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-W050088SSize:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Isoxepac-d6 (HP 549-d6) is the deuterium labeled Isoxepac. Isoxepac (HP 549) is an orally active non-steroidal anti-inflammatory agent. Isoxepac can inhibit Carrageenan (HY-125474) paw oedema, adjuvant-induced polyarthritis, and prostaglandin synthesis. Isoxepac (200 mg) has an analgesic effect after meniscectomy with a low incidence of side effects. Isoxepac can be used in the research of inflammatory (rheumatoid arthritis) and pain-related diseases[1].
CAS Number
2012598-71-7
Product Name Alternative
HP 549-d6
UNSPSC
12352005
Target
Drug Derivative; Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others
Field of Research
Inflammation/Immunology; Neurological Disease
Solubility
10 mM in DMSO
Smiles
O=C1C2=CC(CC(O)=O)=CC=C2OC([2H])([2H])C3=C([2H])C([2H])=C([2H])C([2H])=C31
Molecular Formula
C16H6D6O4
Molecular Weight
274.30
References & Citations
[1]Illing HP, et al. Species differences in the disposition and metabolism of 6,11-dihydro-11-oxodibenz[be]oxepin-2-acetic acid (isoxepac) in rat, rabbit, dog, rhesus monkey, and man. Drug Metab Dispos. 1978 Sep-Oct;6 (5) :510-7.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported